FOLFOX-Encorafenib/Panitumumab Regimen

**Semantic type:** Therapeutic or Preventive Procedure

**Definition:** A regimen consisting of leucovorin, fluorouracil and oxaliplatin (FOLFOX) plus encorafenib and panitumumab that is used for the treatment of colorectal cancer, appendiceal cancer, and small bowel adenocarcinoma.

**Synonyms:** - Encorafenib-Panitumumab-FOLFOX - Encorafenib/Fluorouracil/Leucovorin/Oxaliplatin/Panitumumab - Encorafenib/Panitumumab Plus FOLFOX - FOLFOX Plus Braftovi-Vectibix - FOLFOX Plus Encorafenib/Panitumumab - FOLFOX Plus Panitumumab/Encorafenib - FOLFOX- Vectibix/Braftovi - FOLFOX-Encorafenib-Panitumumab - FOLFOX-Panitumumab/Encorafenib - FOLFOX/Encorafenib/Panitumumab - FOLFOX/Panitumumab/Encorafenib - Folinic Acid/Fluorouracil/Oxaliplatin/Encorafenib/Panitumumab Regimen - Leucovorin-Fluorouracil-Oxaliplatin-Encorafenib-Panitumumab - Leucovorin/Fluorouracil/Oxaliplatin/Encorafenib/Panitumumab - Panitumumab/Encorafenib Plus FOLFOX - Panitumumab/Encorafenib-FOLFOX